Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025 Vol.282(4) p. 2043-2051

Calim OF, Polat E, Ozturan O

관련 도메인

Abstract

[OBJECTIVES] This study aimed to assess the effectiveness of four-duct ligation following Botulinum toxin-A injections into the parotid and submandibular glands in pediatric patients with sialorrhea resistant to nonsurgical treatments. Prior research has individually explored either surgical or Botulinum toxin interventions; however, the safety and efficacy of the combined approach to these treatments have yet to be documented.

[METHODS] Patients were assessed before surgery and 6, 12, and 24 months post-operatively. Evaluations involved interviews with parents and caregivers, conducted face-to-face or by telephone, using the Drooling Severity and Frequency Scales. Additionally, metrics such as the daily count of bib changes and the hourly frequency of saliva wiping were recorded. Quality-of-life assessments were performed before and after the surgical procedures. All complications associated with the interventions were carefully recorded.

[RESULTS] The study group consisted of 25 participants, with a median age of 6 years (range 2-17 years). Each participant was diagnosed with a neurological, metabolic, or genetic disorder. Evaluations were conducted periodically, culminating in a final follow-up at 24 months. The treatment demonstrated a 100% success rate at six months post-operation (25/25 patients), which slightly decreased to 96% at the 12-month mark (24/25 patients) and further to 84% by the 24-month follow-up (21/25 patients). Major complications were not observed. However, minor complications were reported in six patients (24%): three exhibited temporary facial swelling (12%), two encountered minor bleeding (8%), and one experienced excessive dryness (4%).

[CONCLUSIONS] The combination of Botulinum toxin-A injection 3 weeks prior to the four-duct ligation procedure demonstrated high success rates and substantially reduced the incidence of infectious and cosmetic complications. Consequently, this staggered approach to combination treatment is recommended for managing pediatric sialorrhea cases that are resistant to non-surgical interventions.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 4
해부 parotid scispacy 1
해부 submandibular glands scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 sialorrhea C0037036
Sialorrhea
scispacy 1
질환 Drooling C0013132
Drooling
scispacy 1
질환 swelling C0013604
Edema
scispacy 1
질환 bleeding C0019080
Hemorrhage
scispacy 1
질환 dryness C1512080
Dryness (characteristic)
scispacy 1
질환 infectious and cosmetic complications scispacy 1
기타 four-duct scispacy 1
기타 Botulinum toxin-A injections scispacy 1
기타 patients scispacy 1
기타 Botulinum toxin-A injection 3 scispacy 1

MeSH Terms

Humans; Sialorrhea; Child; Botulinum Toxins, Type A; Female; Male; Ligation; Adolescent; Submandibular Gland; Child, Preschool; Parotid Gland; Treatment Outcome; Quality of Life; Salivary Ducts; Neuromuscular Agents; Injections

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문